Syndromic disorders with short stature

Area of Science:

• Pediatrics
• Genetics
• Endocrinology

Background:

• Short stature is a key feature in numerous dysmorphic syndromes.
• Growth failure mechanisms can involve the growth hormone (GH)/insulin-like growth factor axis or other pathologies.

Purpose of the Study:

• To review common syndromes associated with short stature, including Noonan, Prader-Willi, Silver-Russell, and Aarskog-Scott syndromes.
• To discuss the role and controversies surrounding growth hormone (GH) therapy in these conditions.

Main Methods:

• Literature review of frequently observed syndromes linked to short stature.
• Analysis of current practices and evidence regarding GH therapy in syndromic short stature.

Main Results:

• Syndromes discussed present with endocrinopathies, developmental, systemic, and behavioral issues.
• GH therapy is widely used but lacks sufficient long-term outcome data and presents dosing/safety controversies.

Conclusions:

• Comprehensive patient evaluation is crucial before initiating GH treatment for syndromic short stature.
• Further research is needed to clarify optimal GH therapy protocols and long-term effects in these disorders.